ATS 2024 Final Program

Click on the session title to view the speakers

117

MONDAY • MAY 20

Objectives At the conclusion of this session, the participant will be able to: • develop a comprehensive understanding of biomarkers development. Learners will be better able to understand the methods and barriers for biomarker development, validation, and implementation into clinical practice • promote and seek interdisciplinary and cross-subspecialty collaboration. By the end of the session, learners will have an understanding of the importance of collaborative discovery in biomarker research to enhance patient care • understand the performance and utility of disease-specific biomarkers in chronic respiratory disease. At the end of this session, learners will understand the role of biomarkers to improve patient outcomes Biomarker development is an arduous process, with few molecular findings translated into clinical practice. Once a biomarker with potential clinical relevance is identified, multiple critical steps are required to move the biomarker from discovery to deliverable. Nearly all biomarker research is performed in single pulmonary conditions. As chronic lung disease remains a leading cause of death worldwide, it is imperative that we collectively capitalize on successful biomarker development and learn from biomarker failures. This scientific symposium will discuss what constitutes a clinically relevant biomarker, necessary steps for developing clinically relevant biomarkers and highlight biomarker successes in COPD, ILD and bronchiectasis. 9:15 Introduction to Session: What Is a Clinically Relevant Biomarker? 9:25 Discussion 9:30 The Hunt for COPD’s Best Biomarker 9:45 Discussion 9:50 Pushing the Paradigm Towards Precision: ILD’s Best Biomarkers 10:05 Discussion 10:10 Probing the Inflammatory Milieu: Biomarkers for Bronchiectasis 10:25 Discussion 10:30 Best Bronchoscopic Biomarkers: It Will All Come Out in the Wash 10:40 Discussion This session and the International Conference are supported

YEAR IN REVIEW

CLINICAL YEAR IN REVIEW 1

B1

9:15 A.M. - 10:45 A.M.

San Diego Convention Center Ballroom 20B-D (Upper Level)

Target Audience Pulmonary, critical care and sleep providers. Objectives

At the conclusion of this session, the participant will be able to: • apply new clinical research knowledge to clinical practice • apply new findings about key conditions in pulmonary, critical care and sleep • learn new strategies to manage the care of common conditions in pulmonary, critical care, and sleep The program will discuss general topics of interest to a broad group of providers, inside and outside of these subspecialties. The program is relevant to not only clinicians, but also to researchers and administrators. 9:15 COPD 9:37 Critical Care 9:59 Global Lung Health 10:23 Tuberculosis BASIC • CLINICAL • TRANSLATIONAL CLINICAL TOPICS IN PULMONARY MEDICINE B2 BRING YOUR BEST BIOMARKER: MOLECULAR SUCCESS STORIES IN CHRONIC LUNG DISEASE Assemblies on Clinical Problems; Allergy, Immunology and Inflammation 9:15 a.m. - 10:45 a.m. Marriott Marquis San Diego Marina Grand Ballroom 5-6 (Lobby Level, North Tower) Target Audience Providers of lung health including pulmonologists, nurses and allied health practitioners; those serving ILD, bronchiectasis and COPD patient groups; those with interest in the study and clinical application of biomarker in lung disease

by an independent medical educational grant from Boehringer IngelheimPharmaceuticals, Inc.

All CMEsessions have been planned and implemented in accordancewith the Criteria of theAccreditationCouncil for ContinuingMedical Education (ACCME ® ) sand are free of the control of ineligible companies (formerly commercial interests).

ATS 2024 Conference Program • San Diego, CA